Cellectar Biosciences (CLRB)
NASDAQ:CLRB
Holding CLRB?
Track your performance easily

Cellectar Biosciences (CLRB) Technical Analysis

1,250 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cellectar Biosciences’s (CLRB) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Cellectar Biosciences is a Sell.
Cellectar Biosciences’s (CLRB) 20-Day exponential moving average is 2.12, while Cellectar Biosciences’s (CLRB) share price is $2.14, making it a Sell.
Cellectar Biosciences’s (CLRB) 50-Day exponential moving average is 2.25, while Cellectar Biosciences’s (CLRB) share price is $2.14, making it a Sell.

Cellectar Biosciences (CLRB) Pivot Points

Sep 20, 2024, 02:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.96
2.02
2.06
2.12
2.17
2.23
2.27
Fibonacci
2.02
2.06
2.08
2.12
2.16
2.19
2.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cellectar Biosciences (CLRB) Moving Averages

Sep 20, 2024, 02:47 AM
Period
Simple
Exponential
MA5
2.11Sell
2.10Sell
MA10
2.11Sell
2.11Sell
MA20
2.13Sell
2.12Sell
MA50
2.20Sell
2.25Sell
MA100
2.60Sell
2.50Sell
MA200
2.99Sell
2.71Sell
Cellectar Biosciences’s (CLRB) 10-Day exponential moving average is 2.11, while Cellectar Biosciences’s (CLRB) share price is $2.14, making it a Sell.
Cellectar Biosciences’s (CLRB) 100-Day exponential moving average is 2.50, while Cellectar Biosciences’s (CLRB) share price is $2.14, making it a Sell.
Cellectar Biosciences’s (CLRB) stock price is $2.14 and Cellectar Biosciences’s (CLRB) 50-day simple moving average is 2.20, creating a Sell signal.
Cellectar Biosciences’s (CLRB) stock price is $2.14 and Cellectar Biosciences’s (CLRB) 100-day simple moving average is 2.60, creating a Sell signal.
Cellectar Biosciences’s (CLRB) stock price is $2.14 and Cellectar Biosciences’s (CLRB) 200-day simple moving average is 2.99, creating a Sell signal.

Cellectar Biosciences (CLRB) Technical Indicators

Sep 20, 2024, 02:47 AM
Name
Value
Implied Action
RSI (14)
46.28
Neutral
STOCH (9,6)
34.69
Neutral
STOCHRSI (14)
21.09
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
9.95
Buy
Williams %R
-77.55
Buy
CCI (14)
-1.04
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
40.61
Neutral
ROC
-4.55
Sell
Cellectar Biosciences’s (CLRB) Relative Strength Index (RSI) is 46.28, creating a Neutral signal.
Cellectar Biosciences’s (CLRB) Trend Strength Indicator (ADX) is 9.95, creating a Buy signal.
Cellectar Biosciences’s (CLRB) Commodity Channel Index (CCI) is -1.04, creating a Neutral signal.
Cellectar Biosciences’s (CLRB) Price Rate of Change (ROC) is -4.55, creating a Sell signal.

FAQ

Is CLRB a Buy, Hold, or Sell?
Based on CLRB’s technical indicators, CLRB is a Strong Sell.
    What is CLRB’s RSI (14)?
    CLRB’s RSI (14) is 46.28, which suggests CLRB is a Neutral.
      What is CLRB’s MACD?
      CLRB’s MACD is -0.02, which suggests CLRB is a Sell.
        What is CLRB’s 5-day moving average?
        CLRB’s 5-day moving average is 2.11, which suggests CLRB is a Sell.
          What is CLRB’s 20-day moving average?
          CLRB 20-day moving average is 2.13, which suggests CLRB is a Sell.
            What is CLRB’s 50-day moving average?
            CLRB’s 50-day moving average is 2.20, which suggests CLRB is a Sell.
              What is CLRB’s 200-day moving average?
              CLRB’s 200-day moving average is 2.99, which suggests CLRB is a Sell.
                What is CLRB’s Williams % R (14)?
                CLRB’s Williams % R (14) is -77.55, which suggests CLRB is a Buy.
                  What is CLRB’s CCI (14)?
                  CLRB’s CCI (14) is -1.04, which suggests CLRB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis